Top 5 Stock Picks of Samuel Isaly’s OrbiMed Advisors

Page 5 of 5

1. SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)

OrbiMed Advisors Stake Value: $382,436,000
Percentage of OrbiMed Advisors’ 13F Portfolio: 4.2%
Number of Hedge Fund Holders: 21

SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) is a clinical-stage biopharmaceutical company focused on acquiring, developing, and commercializing pharmaceuticals using a precision medicine strategy. OrbiMed Advisors holds 6.03 million shares in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX), worth over $382.44 million, representing 4.2% of its Q3 portfolio. The hedge fund decreased its stake in the company by 1% in the third quarter of 2021.

SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) and AbbVie Inc. (NYSE:ABBV) signed a clinical trial partnership agreement in December to investigate Nirogacestat in patients with relapsed or refractory multiple myeloma.

In the third quarter, fund managers added to their SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) holdings. 21 hedge funds in our database held stakes in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) at the end of the third quarter, compared to 18 funds in the second quarter.

You can also take a peek at 10 Top Stock Picks of Mario Gabelli and 10 Top Stock Picks of Ray Dalio.

Page 5 of 5